Tags

Type your tag names separated by a space and hit enter

Palliation of oral mucositis symptoms in pediatric patients treated with cancer chemotherapy.
Cancer Nurs 2003; 26(6):476-84CN

Abstract

This prospective randomized 2-period crossover study aimed at comparing the efficacy of 2 oral care protocols differing in the type of mouthwashes: chlorhexidine versus benzydamine in alleviating oral mucositis symptoms for children undergoing chemotherapy. Forty subjects were randomly allocated to receive either chlorhexidine first then benzydamine protocols or benzydamine first then chlorhexidine protocols. Each protocol was started on the first day of chemotherapy and continued for 21 days. Subjects were evaluated in intervals of 3 to 4 days using the World Health Organization (WHO) grading for mucositis and 10-cm visual analogue scale for oral symptoms evaluations. Among 34 evaluable subjects, 26% and 48% of them using chlorhexidine and benzydamine had WHO grade II mucositis, respectively (P < .05). The results revealed a significant difference in mean area under the curve (AUC) of mouth pain (1.35 +/- 2.26 versus 3.09 +/- 3.21) (P = .05), and a trend of a lessening of mean AUC of difficulty in eating/chewing (2.49 +/- 3.74 versus 2.71 +/- 4.1) (P = .82) and swallowing (1.34 +/- 3.31 versus 1.91 +/- 4.03) (P = .53) for subjects receiving chlorhexidine compared to those receiving benzydamine. In conclusion, chlorhexidine may be helpful in palliating mucositis symptoms for children in chemotherapy. The beneficial effect, however, is small and needs to be confirmed in a larger trial.

Authors+Show Affiliations

Nethersole School of Nursing, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong. kariskwong@cuhk.edu.hkNo affiliation info available

Pub Type(s)

Clinical Trial
Comparative Study
Journal Article
Randomized Controlled Trial

Language

eng

PubMed ID

15022979

Citation

Cheng, K K F., and A M. Chang. "Palliation of Oral Mucositis Symptoms in Pediatric Patients Treated With Cancer Chemotherapy." Cancer Nursing, vol. 26, no. 6, 2003, pp. 476-84.
Cheng KK, Chang AM. Palliation of oral mucositis symptoms in pediatric patients treated with cancer chemotherapy. Cancer Nurs. 2003;26(6):476-84.
Cheng, K. K., & Chang, A. M. (2003). Palliation of oral mucositis symptoms in pediatric patients treated with cancer chemotherapy. Cancer Nursing, 26(6), pp. 476-84.
Cheng KK, Chang AM. Palliation of Oral Mucositis Symptoms in Pediatric Patients Treated With Cancer Chemotherapy. Cancer Nurs. 2003;26(6):476-84. PubMed PMID: 15022979.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Palliation of oral mucositis symptoms in pediatric patients treated with cancer chemotherapy. AU - Cheng,K K F, AU - Chang,A M, PY - 2004/3/17/pubmed PY - 2004/4/1/medline PY - 2004/3/17/entrez SP - 476 EP - 84 JF - Cancer nursing JO - Cancer Nurs VL - 26 IS - 6 N2 - This prospective randomized 2-period crossover study aimed at comparing the efficacy of 2 oral care protocols differing in the type of mouthwashes: chlorhexidine versus benzydamine in alleviating oral mucositis symptoms for children undergoing chemotherapy. Forty subjects were randomly allocated to receive either chlorhexidine first then benzydamine protocols or benzydamine first then chlorhexidine protocols. Each protocol was started on the first day of chemotherapy and continued for 21 days. Subjects were evaluated in intervals of 3 to 4 days using the World Health Organization (WHO) grading for mucositis and 10-cm visual analogue scale for oral symptoms evaluations. Among 34 evaluable subjects, 26% and 48% of them using chlorhexidine and benzydamine had WHO grade II mucositis, respectively (P < .05). The results revealed a significant difference in mean area under the curve (AUC) of mouth pain (1.35 +/- 2.26 versus 3.09 +/- 3.21) (P = .05), and a trend of a lessening of mean AUC of difficulty in eating/chewing (2.49 +/- 3.74 versus 2.71 +/- 4.1) (P = .82) and swallowing (1.34 +/- 3.31 versus 1.91 +/- 4.03) (P = .53) for subjects receiving chlorhexidine compared to those receiving benzydamine. In conclusion, chlorhexidine may be helpful in palliating mucositis symptoms for children in chemotherapy. The beneficial effect, however, is small and needs to be confirmed in a larger trial. SN - 0162-220X UR - https://www.unboundmedicine.com/medline/citation/15022979/Palliation_of_oral_mucositis_symptoms_in_pediatric_patients_treated_with_cancer_chemotherapy_ L2 - http://dx.doi.org/10.1097/00002820-200312000-00007 DB - PRIME DP - Unbound Medicine ER -